Ipomoea batatas attenuates amyloid β peptide-induced neurotoxicity in ICR mice

Journal of Medicinal Food

Volumn 14, Issue 3, 2011, Pages 304-309

  Kim, Jae Kyeom ^a,b   Choi, Soo Jung ^a   Cho, Hong Yon ^a   Kim, Young Jun ^a   Lim, Seung Taik ^a   Kim, Chang Ju ^c   Kim, Eun Ki ^d   Kim, Hye Kyung ^e   Peterson, Sabrina ^b   Shin, Dong Hoon ^a  

^a Korea University   (South Korea)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Kyung Hee University   (South Korea)

^d Inha University   (South Korea)

^e Hanseo University   (South Korea)

Author keywords

Alzheimer's disease; amyloid peptide; Ipomoea batatas; neurotoxicity; oxidative stress

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN; CATALASE; DICHLORODIHYDROFLUORESCEIN DIACETATE; PLANT EXTRACT; SWEET POTATO EXTRACT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN TISSUE; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEEDING; LIPID PEROXIDATION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SWEET POTATO;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; CATALASE; IPOMOEA BATATAS; LIPID PEROXIDATION; MICE; MICE, INBRED ICR; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS;

IPOMOEA BATATAS; MUS;

EID: 79951995117     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2010.0047     Document Type: Article

References (28)

1. Reiman EM, Caselli RJ: Alzheimer's disease. Maturitas 1999;31:185-200. (Pubitemid 29132820)
2. Butterfield DA, Castegna A, Lauderback CM, Drake J: Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 2002;23:655-664. (Pubitemid 35217687)
3. Behl C: Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 1997;290:471-480.
4. Reiter RJ: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 1995;9:526-533.
5. Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S: A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 2002;23:719-735. (Pubitemid 35217698)
6. Dizdaroglu M, Nackerdien Z, Chao BC, Gajewski E, Rao G: Chemical nature of in vivo DNA base damage in hydrogen peroxide-treated mammalian cells. Arch Biochem Biophys 1991;285:388-390.
7. Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B: An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 1997;68:2061-2069. (Pubitemid 27176143)
8. Bovell-BenjaminAC: Sweet potato: a reviewof its past, present, and future role in human nutrition. Adv Food Nutr Res 2007;52:1-59.
9. Rabah IO, Hou DX, Komine S, Fujii M: Potential chemopreventive properties of extract from baked sweet potato (Ipomoea batatas Lam. Cv. Koganesengan). J Agric Food Chem 2004;52:7152-7157.
10. Choi SJ, Kim MJ, Heo HJ, et al.: Protective effect of Rosa laevigata against amyloid beta peptide-induced oxidative stress. Amyloid 2006;13:6-12.
11. Wolfe KL, Liu RH: Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J Agric Food Chem 2007;55:8896-8907. (Pubitemid 350105534)
12. Kim DO, Heo HJ, Kim YJ, Yang HS, Lee CY: Sweet and sour cherry phenolics and their protective effects on neuronal cells. J Agric Food Chem 2005;53:9921-9927.
13. Mihara M, Uchiyama M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-278. (Pubitemid 9050395)
14. Choi-Kwon S, Park KA, Lee HJ, et al.: Temporal changes in cerebral antioxidant enzyme activities after ischemia and reperfusion in a rat focal brain ischemia model: effect of dietary fish oil. Brain Res Dev Brain Res 2004;152:11-18. (Pubitemid 38993283)
15. Giacobini E: Cholinergic foundations of Alzheimer's disease therapy. J Physiol Paris 1998;92:283-287.
16. Qizilbash N, Whitehead A, Higgins J, Wilcock G, Schneider L, Farlow M: Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration. JAMA 1998;280:1777-1782. (Pubitemid 28536880)
17. Reddy PH, Beal MF: Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 2008;14:45-53.
18. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T: Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009;87:181-194.
19. Behl C: Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol 1999;57:301-323.
20. Steed LE, Truong VD: Anthocyanin content, antioxidant activity, and selected physical properties of flowable purple-fleshed sweetpotato purees. J Food Sci 2008;73:S215-S221. (Pubitemid 351813341)
21. Maurice T, Lockhart BP, Privat A: Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 1996;706:181-193. (Pubitemid 26048681)
22. Lovell MA, Ehmann WD, Butler SM, Markesbery WR: Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995;45:1594-1601.
23. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR: Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 1998;23:81-88. (Pubitemid 28145695)
24. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP: A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 1997;68:255-264. (Pubitemid 26427315)
25. Lovell MA, Xie C, Markesbery WR: Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med 2000;29:714-720.
26. Lovell MA, Xie C, Markesbery WR: Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 2001;22:187-194. (Pubitemid 32162967)
27. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA: Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005;93:953-962. (Pubitemid 40695754)
28. Moreira PI, Siedlak SL, Aliev G, et al.: Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. J Neural Transm 2005;112:921-932. (Pubitemid 40869081)